Optimal Management of Venous Thromboembolism in Patients with Cancer
Surveys suggest that patient and clinician education on cancer-associated VTE and safe use of DOACs is lacking, despite the fact that VTE is a major contributor to mortality among cancer patients.
  • Venous Thromboembolic Disease
  • Recorded Webcast
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation